Skip to main content
Oxford University Hospitals NHS Foundation Trust
Cancer Services

Alert Coronavirus / COVID-19

If you have a new continuous cough, a high temperature, or a loss or change to your sense of taste or smell, do not come to our hospitals. Follow the national advice on coronavirus (COVID-19).

Please find information on our services and visiting restrictions in our COVID-19 section.

Patients and visitors must wear a face covering in our hospitals.

This site is best viewed with a modern browser. You appear to be using an old version of Internet Explorer.

Gynaecological Oncology MDT

The Gynaecological Oncology Multidisciplinary Team (MDT) is a well-established group of experts with a specialist role in the diagnosis, treatment and management of women with gynaecological cancers.

The team comprises doctors, nurses and other healthcare professionals who manage the treatment of gynaecological cancers in Oxfordshire and is the tertiary referral centre for the Thames Valley Cancer Network.

The team meets every Monday to discuss, in confidence, newly referred patients with a suspected or confirmed diagnosis of a gynaecological cancer. The MDT meetings offer a forum for the team members to plan and agree a recommended programme of treatment specific to individual patient needs.

This approach ensures that all necessary investigations are carried out as quickly as possible and the best available treatment is offered. Treatment options are then discussed with the patient and her family at a subsequent appointment, which is often later that week.

The Gynaecological Oncology MDT links with all those engaged in gynaecological cancer care within the Thames Valley Cancer Network via video-linked joint MDT meetings with colleagues in Aylesbury, High Wycombe, Reading and Swindon and liaises with community and primary care teams.

The Gynaecological Oncology MDT includes these core members.

Gynaeoncology Surgery

Professor Sean Kehoe

Lead Clinician for the Gynaecological Oncology Service

Professor Kehoe graduated from Trinity College Dublin in 1983 and trained as a Gynaecological Oncologist in Birmingham. He is a past President of the British Gynaecological Cancer Society, a Senior Research Fellow at St Peters College Oxford and a Trustee of the charity OVACOME. He has worked at consultant level since 1997 and his main research interests are in ovarian and vulval cancers.

He was lead for the CHORUS trial, which has influenced change in the care of women with advanced ovarian cancer in the UK and abroad. He is involved with international societies, is on the editorial boards of journals, has many peer-reviewed publications and is invited to lecture at numerous societies throughout the world.

Miss Beena Abdul

Consultant Gynaecological Oncology Surgeon

Mr Moiad Alazzam

Consultant Gynaecological Oncology Surgeon

Mr Moiad Alazzam is a recognised expert in complex gynaecological surgery both open and minimally-invasive, including laparoscopy, robotics and hysteroscopic surgery.

Moiad is an experienced ultraradical surgeon for advanced and recurrent ovarian cancer with complete cytoreduction rate over 80 percent. Moiad has a special interest in microsurgery and fertility-preserving surgical techniques. Since moving to Oxford he has joined the regional service for Abnormal Invasive Placenta (AIP).

Moiad is actively involved in research. He is widely published and frequently invited to speak at national and international meetings. His main area of interest is health innovation and technology. He is a member of several national and international societies, a previous council member of British Society of Gynaecological Endoscopy (BSGE) and has chaired the guidelines and robotics subcommittees.

Mr Hooman Soleymani Majd

Consultant Gynaecological Oncology Surgeon

Hooman Soleymani Majd

Mr Hooman Soleymani Majd started his Obstetrics and Gynaecology career in London, before moving to Oxford where he completed his structured postgraduate training programme. During the course of training he obtained his Member of the Royal College of Obstetricians and Gynaecologists (MRCOG), which culminated in a Certificate of Completion of Training (CCT) in Obstetrics and Gynaecology. Mr. Soleymani Majd completed a further three years of Sub-Specialty Training in Gynaecological Oncology at the Churchill Cancer Centre in Oxford and is also a BSCCP accredited Colposcopist, as well as a member of the British Gynaecological Cancer Society (BGCS).

He is an accomplished and experienced advanced laparoscopic surgeon, performing complex radical laparoscopic surgeries for uterine and cervical cancer. He has a special interest in performing ultra-radical surgery for ovarian cancer; his skill set includes upper abdominal surgery, liver mobilisation and diaphragmatic reconstruction. Mr Soleymani Majd also has a particular surgical interest in treating patients with Abnormally Invasive Placentas (AIP).

Mr Soleymani Majd has active involvement in teaching registrars/fellows and medical students from Oxford University. He is part of an Oxford research group that has a special interest in new developments in surgical techniques in ultra-radical surgery for advanced ovarian cancer, he has published many papers and been invited to speak at a number of international congresses.

Mr Soleymani Majd currently works as a Consultant in Gynaecological Oncology at the Churchill Hospital, Oxford.

To view some of the surgical procedures that Mr Soleymani Majd and the team have undertaken, please visit:

Clinical Oncology

Dr Amanda Horne

Consultant Clinical Oncologist

Dr Horne graduated from Queens University Belfast and completed her specialist training in Clinical Oncology in the Oxford training scheme. She was appointed as a Consultant Clinical Oncologist at the Cancer Centre in 2004.

She specialises in the treatment of gynaecological cancers, treating patients with radiotherapy, Image Guided Adaptive Brachytherapy (IGABT) using high dose rate (HDR) brachytherapy, and chemotherapy.

Dr Sally Trent

Consultant Clinical Oncologist

Dr Trent graduated from the University of London and completed her specialist training in Clinical Oncology in the pan-London training scheme. She was appointed as a Consultant Clinical Oncologist at the Cancer Centre in 2006.
She specialises in the treatment of gynaecological cancers, treating patients with radiotherapy, Image Guided Adaptive Brachytherapy (IGABT) using high dose rate (HDR) brachytherapy, and chemotherapy.

Loryn Caulfield

Consultant Therapeutic Radiographer

Loryn Caulfield works as part of our healthcare team, offering advice and support to women with gynaecological cancer throughout their radiotherapy journey from referral to follow-up.

Tel: 01865 227213 Bleep 5303

Medical Oncology

Dr Shibani Nicum

Dr Shibani Nicum is a Consultant Medical Oncologist specialising in the treatment of patients with ovarian and other gynaecological cancers at the Oxford Cancer Centre.

She graduated from the University of Birmingham and completed her specialist Medical Oncology training at the Royal Marsden Hospital in London, prior to taking up her current post at the Cancer Centre in Oxford in 2009.

Her particular interests are in BRCA mutated cancers, and the development of new therapies in order to personalise patient care.

Dr Nicum won a national peer-reviewed grant from Cancer Research UK to undertake laboratory-based research and was awarded a DPhil from the University of Oxford in 2007. She has also co-authored many peer-reviewed journal articles and book chapters in the field of medical oncology.

Dr Nicum is the Oxford Gynaeoncology Research Lead and is actively involved in translating advances in the laboratory into benefit for patients. She is the Chief Investigator for the CRUK OCTOVA Trial, the 6MP BRCA trial and the upcoming ICON9 Trial. She is also the Principal Investigator for a number of clinical trials of novel agents for women with advanced malignancies. Dr Nicum is also an active committee member of the UK National Cancer Research Institute Gynaecological Oncology Clinical Studies Group and also the Ovarian Cancer Clinical Studies Subgroup.

Dr René Roux

Consultant Medical Oncologist

Dr Roux trained in South Africa before embarking on a career in the UK.

She completed her specialist training in London after undertaking a period of research at the Institute for Cancer Research and joined the team in Oxford in 2016. She specialises in the systemic treatment of patients with ovarian and other gynaecological cancers.

She is the Principal Investigator for several national and international clinical trials including ovarian, endometrial and advanced cervical cancers. She is also interested in the use of novel agents and treatment combinations in ovarian cancer including PARP inhibitors and other targeted agents.

She is Gynaecology research lead for the Thames Valley Cancer Research Network.


  • Dr Stephen Damato
  • Dr Sunanda Dhar
  • Dr Sanjiv Manek
  • Dr Mark McCole


  • Dr Zoe Traill
  • Dr Catherine Johnson

Clinical Nurse Specialist / Key Worker

Clinical Nurse Specialists (CNS) are senior nurses who work as core members of our team.

They have specific specialist knowledge and experience of patients diagnosed with a gynaecological cancer.

For more information and contact details please visit:

Gynaeoncology Nurse Specialists

Further information

Fertility preservation

We now offer a service which preserves fertility in patients undergoing chemotherapy or radiotherapy. This involves the freezing of ovarian or testicular tissue for reimplantation later in life.

For more information please visit:

Fertility preservation: tissue cryopreservation

Find us and contact us

Tel: 0300 304 7777

Surgical Team / Pathway Administrators

Tel: 01865 235662 / 572261


MDT Coordinator

Gynaeoncology Cancer Pathway Coordinator: 01865 235362

MDT referrals:

Medical Oncology and Clinical Oncology Speciality Coordinator

Tel: 01865 225432